{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:42:48Z","timestamp":1784122968405,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Liaoning Province Educational Department","doi-asserted-by":"publisher","award":["LJ222511258012"],"award-info":[{"award-number":["LJ222511258012"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clnesp.2025.09.019","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:15:27Z","timestamp":1758705327000},"page":"119-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum creatinine and cystatin C-based index is a prognostic factor in patients with nonmetastatic breast cancer after surgery"],"prefix":"10.1016","volume":"70","author":[{"given":"Ruoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2025.09.019_bib1","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clnesp.2025.09.019_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/ajco.13958","article-title":"Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries","volume":"19","author":"Tao","year":"2023","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib3","first-page":"328","article-title":"Prevalence and clinical implications of Sarcopenia in breast cancer: a systematic review and meta-analysis","volume":"32","author":"Jang","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnesp.2025.09.019_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae052","article-title":"The conceptual definition of Sarcopenia: Delphi consensus from the global leadership initiative in Sarcopenia (GLIS)","volume":"53","author":"Kirk","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2025.09.019_bib5","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","article-title":"Evaluating muscle mass by using markers of kidney function: development of the Sarcopenia index","volume":"45","author":"Kashani","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clnesp.2025.09.019_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.02870707","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13539-012-0079-1","article-title":"Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature","volume":"4","author":"Patel","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2025.09.019_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00223-022-01054-z","volume":"112","author":"Ladang","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clnesp.2025.09.019_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10157-020-01981-x","article-title":"Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with Sarcopenia","volume":"25","author":"Kusunoki","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib10","article-title":"Sarcopenia index as a predictor of clinical outcomes in older patients with coronary artery disease","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.clnesp.2025.09.019_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1155520","article-title":"Serum creatinine\/cystatin C ratio as a prognostic indicator for patients with colorectal cancer","volume":"13","author":"Gao","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib12","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jcsm.13006","article-title":"Creatinine-cystatin C ratio and mortality in cancer patients: a retrospective cohort study","volume":"13","author":"Jung","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2025.09.019_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110895","article-title":"Creatinine-to-cystatin C ratio and bioelectrical impedance analysis for the assessment of low lean body mass in cancer patients: Comparison to L3-computed tomography scan","volume":"81","author":"Ulmann","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2025.09.019_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjmed.2017.01.018","article-title":"Looking for Sarcopenia biomarkers","volume":"130","author":"Lien","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.clnesp.2025.09.019_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afad252","article-title":"Diagnostic test accuracy of serum creatinine and cystatin C-based index for Sarcopenia: a systematic review and meta-analysis","volume":"53","author":"Lin","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2025.09.019_bib16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.clnesp.2025.09.019_bib17","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clnesp.2025.09.019_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12916-023-03225-7","article-title":"Cholesterol-modified prognostic nutritional index (CPNI) as an effective tool for assessing the nutrition status and predicting survival in patients with breast cancer","volume":"21","author":"Shi","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.clnesp.2025.09.019_bib19","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jcsm.13032","article-title":"The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer","volume":"13","author":"Song","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2025.09.019_bib20","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/gerona\/glz034","article-title":"Approaches to assessment of muscle mass and myosteatosis on computed tomography: a systematic review","volume":"74","author":"Amini","year":"2019","journal-title":"J Gerontol: Series A"},{"key":"10.1016\/j.clnesp.2025.09.019_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/apha.12224","article-title":"Measurement of skeletal muscle radiation attenuation and basis of its biological variation","volume":"210","author":"Aubrey","year":"2014","journal-title":"Acta Physiol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib23","series-title":"R: a language and environment for statistical computing","year":"2024"},{"key":"10.1016\/j.clnesp.2025.09.019_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235020","article-title":"A new index based on serum creatinine and cystatin C can predict the risks of Sarcopenia, falls and fractures in old patients with low bone mineral density","volume":"14","author":"Ge","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.09.019_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12877-023-03784-7","article-title":"Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clnesp.2025.09.019_bib26","article-title":"Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: a retrospective cohort study from the China health and retirement longitudinal study","volume":"11","author":"Wu","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.clnesp.2025.09.019_bib27","doi-asserted-by":"crossref","first-page":"e1219","DOI":"10.1093\/oncolo\/oyad218","article-title":"Creatinine to Cystatin-C ratio in renal cell carcinoma: a clinically pragmatic prognostic factor and Sarcopenia biomarker","volume":"28","author":"Schmeusser","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.clnesp.2025.09.019_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ags3.12671","article-title":"Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer","volume":"7","author":"Tsukagoshi","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.clnesp.2025.09.019_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.963265","article-title":"Serum creatinine\/cystatin C ratio is a systemic marker of Sarcopenia in patients with gastrointestinal stromal tumours","volume":"9","author":"Ding","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2025.09.019_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12877-022-02925-8","article-title":"Serum creatinine\/cystatin C ratio as a screening tool for Sarcopenia and prognostic indicator for patients with esophageal cancer","volume":"22","author":"Zheng","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clnesp.2025.09.019_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clnesp.2022.07.010","article-title":"Relationship between the creatinine\/cystatin C ratio and muscle mass measured by CT-scan in cancer patients","volume":"51","author":"Tlemsani","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnesp.2025.09.019_bib32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.clnu.2023.03.023","article-title":"Impact of Sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors","volume":"42","author":"Ashton","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.09.019_bib33","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/jcsm.12977","article-title":"Serum creatinine and cystatin C-based diagnostic indices for Sarcopenia in advanced non-small cell lung cancer","volume":"13","author":"Tang","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2025.09.019_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12876-022-02093-4","article-title":"Serum creatinine\/cystatin C ratio as a surrogate marker for Sarcopenia in patients with gastric cancer","volume":"22","author":"Sun","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib35","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10147-024-02539-7","article-title":"Impact of the serum creatinine and cystatin C ratio for prediction of Sarcopenia and prognosis in biliary tract cancer","volume":"29","author":"Fukushima","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/codi.14558","article-title":"A new diagnostic index for Sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer","volume":"21","author":"Yang","year":"2019","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clnesp.2025.09.019_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.111032","article-title":"A new index based on serum creatinine and cystatin C is useful for assessing Sarcopenia in patients with advanced cancer","volume":"82","author":"Fu","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2025.09.019_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101030","article-title":"Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study","volume":"38","author":"Lees","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.clnesp.2025.09.019_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/ejh.12164","volume":"91","author":"Terpos","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib40","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/ckj\/sfac070","article-title":"Cystatin C-based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the china health and retirement longitudinal study (CHARLS)","volume":"15","author":"Zhu","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.clnesp.2025.09.019_bib41","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/jcpt.13501","article-title":"Evaluation of renal function using cystatin C-based estimated glomerular filtration rate in patients with urothelial carcinoma treated with gemcitabine and cisplatin chemotherapy","volume":"46","author":"Nishimura","year":"2021","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.clnesp.2025.09.019_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00066-010-2203-5","article-title":"Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients","volume":"187","author":"Bolke","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000504084","article-title":"Prognostic value of cystatin C-Derived estimated glomerular filtration rate in patients with acute heart failure","volume":"10","author":"Jang","year":"2020","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.clnesp.2025.09.019_bib44","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34208","article-title":"Association of cystatin C kidney function measures with long-term deficit-accumulation frailty trajectories and physical function decline","volume":"5","author":"Li","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clnesp.2025.09.019_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12885-019-5442-6","article-title":"Prognostic models for breast cancer: a systematic review","volume":"19","author":"Phung","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clnesp.2025.09.019_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02967572","article-title":"Prognostic and predictive factors in the adjuvant treatment of breast cancer","volume":"9","author":"Fukutomi","year":"2002","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clnesp.2025.09.019_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bjc.1982.62","article-title":"A prognostic index in primary breast cancer","volume":"45","author":"Haybittle","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnesp.2025.09.019_bib48","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ejca.2007.04.017","article-title":"The Nottingham prognostic Index-from relative to absolute risk prediction","volume":"43","author":"Lundin","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clnesp.2025.09.019_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-022-06682-5","article-title":"A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia","volume":"195","author":"Baade","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clnesp.2025.09.019_bib50","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/bjc.2014.120","article-title":"Nottingham prognostic index plus (NPI+): a modern clinical decision making tool in breast cancer","volume":"110","author":"Rakha","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnesp.2025.09.019_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.biopha.2006.06.007","article-title":"Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham prognostic index in breast cancer","volume":"60","author":"Suen","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clnesp.2025.09.019_bib52","first-page":"861","article-title":"Impact of body composition on outcome in patients with early breast cancer","volume":"26","author":"Deluche","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnesp.2025.09.019_bib53","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clnesp.2025.09.019_bib54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10549-018-4915-7","article-title":"Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer","volume":"172","author":"Song","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clnesp.2025.09.019_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00280-017-3326-5","article-title":"Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity","volume":"80","author":"Bretagne","year":"2017","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725029420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725029420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:36:49Z","timestamp":1764405409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725029420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"alternative-id":["S2405457725029420"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.09.019","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum creatinine and cystatin C-based index is a prognostic factor in patients with nonmetastatic breast cancer after surgery","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}